Shop All
Systemic sclerosis (SSc, scleroderma) is a rare autoimmune connective tissue disease affecting 300,000 Americans, characterized by progressive skin and organ fibrosis, Raynaud's phenomenon, and vascular damage. SSc is driven by TGF-beta1 myofibroblast activation, anti-Scl-70/anticentromere antibodies, endothelial injury, and collagen overproduction. Sea moss fucoidan demonstrates anti-fibrotic properties via TGF-beta inhibition; selenium supports GPx antioxidant protection against oxidative vascular damage; omega-3 precursors modulate Raynaud's vasospastic eicosanoids; zinc supports Treg immune regulation. Calcium channel blockers, immunosuppressants (mycophenolate, cyclophosphamide), and antifibrotics (nintedanib) are standard; sea moss provides multi-target nutritional support alongside rheumatologist care.
